Greif (GEF)
(Delayed Data from NYSE)
$59.66 USD
+2.70 (4.74%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $59.67 +0.01 (0.02%) 4:22 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Price, Consensus and EPS Surprise
GEF 59.66 +2.70(4.74%)
Will GEF be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for GEF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GEF
Greif (GEF) Stock Declines 7% in a Month: Factors to Note
Understanding Greif (GEF) Reliance on International Revenue
GEF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Highlights Packaging Corporation of America, Amcor, AptarGroup, Sealed Air and Greif
Greif (GEF) Q2 Earnings Beat Estimates, Sales Increase Y/Y
5 Packaging Stocks to Watch in a Challenging Industry
Other News for GEF
Greif Enters Oversold Territory
Small-cap, buy-rated stocks with positive estimate revision factors - BofA
Containerboard prices are stronger than estimated, BofA says
Morning Brew: CrowdStrike Joins S&P 500, Micron's Target Raised, Alimera Sciences Acquired
Oppenheimer spotlights top buy/sell ideas for mid and small cap names